Latest Blogs

Feb 27, 2024
Dr. Faye Lim describes her experience as a faculty member on multidisciplinary team management at events in Sarawak, Malaysia.
Feb 27, 2024
Dr. Ellen Zhang's original poem was composed in honor of her grandmother and her patients.
Feb 15, 2024
This year’s recipients were indeed distinguished leaders in their fields and have dedicated their careers to improve diagnosis, outcomes, and quality of life as well advancing personalized therapy for patients. 
Feb 08, 2024
Dr. Shaalan Beg and Dr. Noelle LoConte consider how oncology organizations can balance the availability of alcoholic beverages at events with the evidence that alcohol consumption can increase cancer risk.
Subscribe to this column

Don S. Dizon, MD, FACP, FASCO

Don S. Dizon, MD, FACP, FASCO, is a professor of medicine and professor of surgery at Brown University, director of the Pelvic Malignancies Program and Hematology-Oncology Outpatient Clinics at Lifespan Cancer Institute, and director of Medical Oncology and the Sexual Health First Responders Clinic at Rhode Island Hospital. He also serves as the head of community outreach and engagement of the Legorreta Cancer Center at Brown University. Dr. Dizon has served as past chair of ASCO's Social Media Working Group and the Cancer Communications Committee. In addition to his regular column on, which has been honored with APEX awards in 2013 and 2014, he is a blogger for The Oncologist and a section editor of Gynecologic Oncology at UpToDate. Dr. Dizon is a member of the JCO Oncology Practice Editorial Board, and editor in chief of the ASCO Educational Book. Follow Dr. Dizon across social media channels @drdonsdizon. 


Mar 22, 2012
Earlier this week I passed my friend and colleague, Dr. Ekaterini Tsiapali, in the stairwell. We rarely get to catch up these days, so it was really quite a nice surprise to see her."What...
Mar 10, 2012
I have to admit it. Even today, I find interpreting statistics for patients very difficult; not because I don't understand the concept of relative and absolute risks, hazard or odds ratios, or survival rates. It's because in the end, they do not apply at an individual level.
Feb 11, 2012
The controversy that has erupted regarding the Susan G. Komen foundation and recent decisions about funding Planned Parenthood has been hard to miss. As a specialist in women's cancers and given my general interest in women's health, I've been fascinated by this dialogue online—on message boards,...
Feb 04, 2012
Last week I attended the semi-annual meeting of the Gynecologic Oncology Group, the cooperative group focused on trials for gynecologic cancers. Over two days I was engaged in updates of ongoing clinical trials and discussion of new trial concepts for ovarian,...
Jan 24, 2012
When I tell people I am an oncologist, I usually get the same response: "That must be so depressing! How do you stand it?" I remember having members of my own family ask me that way back when I was a medical resident as I made the decision to enter oncology. Now that I am in a position where I...
Jan 10, 2012
Recently, a very dear friend learned that her breast cancer (diagnosed in 2010) had spread to her brain. Despite my many years as an oncologist, having faced questions from my own patients about "Why me?", "What did I do to deserve this?"—questions I am fully aware have no answer—I found myself...